Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VTA | Ann: Removal from Official List at close 18/12/20 | 18/12/12 | 0 | 1.0K | |||
|
|||||||
VTA | Ann: Suspension from Official Quotation | 11/12/12 | 0 | 762 | |||
|
|||||||
VTA | Ann: Closing Timeline Agreement | 11/12/12 | 0 | 827 | |||
|
|||||||
VTA | Ann: Glencore receives MOFCOM approval for Viterr | 10/12/12 | 0 | 1.4K | |||
|
|||||||
VTA | Ann: Letter Agreement | 12/11/12 | 0 | 1.0K | |||
|
|||||||
VTA | Ann: Viterra provides further update on Glencore | 12/11/12 | 0 | 679 | |||
|
|||||||
VTA | Ann: Letter Agreement | 27/09/12 | 0 | 794 | |||
|
|||||||
VTA | Ann: Viterra Provides Update on Glencore Transact | 27/09/12 | 0 | 684 | |||
|
See All Discussions